TRIPS Agreement

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is an international legal agreement between all the member nations of the World Trade Organization (WTO). It sets the basic rules that countries must follow when dealing with different kinds of intellectual property (IP). This includes things like inventions, artistic works, and brand names.

TRIPS was created during the Uruguay Round of talks under the General Agreement on Tariffs and Trade (GATT) between 1989 and 1990. It was the first time intellectual property laws were part of the global trading system, and it remains the most detailed agreement on this topic.

The agreement requires countries to protect various types of IP, such as copyrights, patents, trademarks, and trade secrets. It also outlines how these rights should be enforced and resolved when there are disagreements. The goal is to encourage innovation and the sharing of technology while balancing the needs of both creators and users. In 2001, the Doha Declaration clarified some parts of TRIPS, emphasizing that access to medicines should be considered when applying these rules.

Background and history

The TRIPS Agreement was negotiated during the Uruguay Round of the General Agreement on Tariffs and Trade (GATT) between 1986 and 1994. It was pushed forward mainly by the United States, with support from the European Union, Japan, and other developed nations. These countries wanted to make sure that rules about intellectual property, like patents and copyrights, were followed around the world.

One special thing about TRIPS is that it has strong ways to make sure countries follow the rules. If a country does not follow TRIPS, other countries can take the issue to the WTO's dispute settlement system to solve the problem.

Requirements

The TRIPS Agreement sets rules to protect intellectual property rights around the world. It ensures that things like books, music, and inventions are protected for a certain time. For example, copyright protection must last at least 50 years, and computer programs are treated the same as books under the law. Patents for inventions must be given for at least 20 years.

The agreement also makes sure that people from one country are treated the same as people from another country when it comes to protecting their intellectual property. This means that if someone from Country A creates something, they should get the same protection in Country B as someone from Country B would. The TRIPS Agreement includes rules from older agreements like the Berne Convention for the Protection of Literary and Artistic Works and the Paris Convention for the Protection of Industrial Property.

Implementation in developing countries

All countries that are members of the World Trade Organization must follow the rules of the TRIPS Agreement, but developing countries were given more time to make changes to their laws. The time for most developing countries to comply ended in 2005, while the least developed countries had until 2013, and for pharmaceutical patents, until January 1, 2016.

Some believe that strict intellectual property rules may slow down development in poorer countries. However, many developing countries have chosen to create strong intellectual property laws, often by copying laws from developed countries or getting help from the World Intellectual Property Organization. One study showed that TRIPS helped increase research and development spending in Indian pharmaceutical companies.

Post-TRIPS expansion

In addition to the basic rules set by the TRIPS agreement, many countries have made special deals to create even stronger protections for intellectual property. These extra rules are called TRIPS+ or TRIPS-Plus, and they can include different types of protections.

Some goals of these agreements are to create laws that stop people from getting around digital protections, make it harder to use compulsory licenses for patents, enforce patent rules more strictly, and work toward new treaties that give broadcasters special rights over the content they share.

Panel reports

In the first ten years of the TRIPS Agreement, 25 complaints were made, leading to important decisions. Some of these decisions include cases about protecting trademarks and geographical indications for foods, patent protection terms, and copyright laws in different countries.

Some key reports include:

• 2005 Panel Report: European Communities – Protection of Trademarks and Geographical Indications for Agricultural Products and Foodstuffs.
• 2000 Panel Report and Appellate Body Report: Canada – Term of Patent Protection.
• 2000 Panel Report: United States – Section 110(5) of the US Copyright Act.
• 2000 Panel Report: Canada – Patent Protection of Pharmaceutical Products.
• 2001 Panel Report and 2002 Appellate Body Report: United States – Section 211 Omnibus Appropriations Act of 1998.
• 1998 Panel Report: India – Patent Protection for Pharmaceutical and Agricultural Chemical Products.
• 1998 Panel Report: Indonesia – Certain Measures Affecting the Automobile Industry.

Criticism

The TRIPS Agreement has faced criticism since it began. Many people argue that it unfairly favors wealthy countries by making rules about intellectual property that push money away from poorer nations. Critics also say it creates unnecessary scarcity, making things harder for countries that might have had more fair rules before.

Some believe TRIPS was created because technology companies in the United States, Japan, and Europe were losing competitiveness. Others argue that the importance of intellectual property for creating new ideas and inventions has been exaggerated. There have also been debates about whether TRIPS helps bring new technologies and investments to low-income countries, with some studies showing mixed results.

Access to essential medicines

One major issue has been access to medicines, especially for diseases like AIDS in Africa. Patents on drugs can make them very expensive, which has caused problems for countries trying to provide healthcare. To address this, the WTO issued the Doha Declaration in 2001, stating that countries could use compulsory licenses to produce generic versions of medicines in emergencies. This means countries can make or import cheaper versions of patented drugs when needed for public health. Later changes in 2005 allowed countries without drug-making facilities to import generic medicines made under compulsory licenses by other countries.

Software and business method patents

There has also been debate about whether TRIPS rules should allow patents on software and business methods. The agreement says patents should be available in all areas of technology, but this has led to disagreements about what kinds of inventions should be patentable.

Main article: Software patents under TRIPS Agreement